Business
Currency:HKD
2023/FY
Stock NameRevenueRatio
生产及销售制药科技产品6.81B64.71%
销售生物技术产品3.38B32.11%
销售核药抗肿瘤诊疗及心脑血管精准介入诊疗科技产品335.39M3.19%
Product
No Data
Region
Currency:HKD
2023/FY
Stock NameRevenueRatio
China8.72B82.83%
United States of America687.45M6.53%
Europe562.25M5.34%
Asia (excl. China)512.09M4.86%
Other45.87M0.44%